CDH1 and carcinoma: Research has demonstrated that re-introduction of E-cadherin into cell lines in which it is depleted promotes reversion of poorly differentiated carcinoma phenotypes (i.e., fibroblastic, highly invasive, poorly cell-cell adherent) to well-differentiated, minimally invasive epithelioid phenotypes with well-developed cell-cell junctions [47].